Sclerotherapy for venous malformations

H. Mimura; K. Shibamoto; Y. Soda; K. Kojima; Y. Matsui; H. Fujiwara; T. Hiraki; H. Gobara; S. Kanazawa

Sclerotherapy for venous malformations

H. Mimura, K. Shibamoto, Y. Soda, K. Kojima, Y. Matsui, H. Fujiwara, T. Hiraki, H. Gobara, S. Kanazawa

University Hospital

Research output: Contribution to journal › Article › peer-review

Abstract

Sclerotherapy is a mainstay in the treatment of venous malformations (VMs). Indications for sclerotherapy of VMs include symptoms such as pain, swelling, hemorrhage, or dysfunction of adjacent organs. Ethanol and detergent sclerosants (for example polidocanol and ethanolamine oleate) are amongst the sclerosants used to treat VMs. To increase the volume and effect of detergent sclerosants, they may be mixed with gas to form a foam. The predictors of a good response after sclerotherapy may be small size, a well-defined margin, and good stasis of sclerosant during sclerotherapy.

Original language	English
Pages (from-to)	524-532
Number of pages	9
Journal	Japanese Journal of Clinical Radiology
Volume	59
Issue number	4
Publication status	Published - Apr 2014

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

Fingerprint Dive into the research topics of 'Sclerotherapy for venous malformations'. Together they form a unique fingerprint.

Cite this

@article{228678c1dcbd4fcd8a797227987ac85f,

title = "Sclerotherapy for venous malformations",

abstract = "Sclerotherapy is a mainstay in the treatment of venous malformations (VMs). Indications for sclerotherapy of VMs include symptoms such as pain, swelling, hemorrhage, or dysfunction of adjacent organs. Ethanol and detergent sclerosants (for example polidocanol and ethanolamine oleate) are amongst the sclerosants used to treat VMs. To increase the volume and effect of detergent sclerosants, they may be mixed with gas to form a foam. The predictors of a good response after sclerotherapy may be small size, a well-defined margin, and good stasis of sclerosant during sclerotherapy.",

author = "H. Mimura and K. Shibamoto and Y. Soda and K. Kojima and Y. Matsui and H. Fujiwara and T. Hiraki and H. Gobara and S. Kanazawa",

year = "2014",

month = apr,

language = "English",

volume = "59",

pages = "524--532",

journal = "Japanese Journal of Clinical Radiology",

issn = "0009-9252",

publisher = "Kanehara Shuppan Co. Ltd",

number = "4",

}

TY - JOUR

T1 - Sclerotherapy for venous malformations

AU - Mimura, H.

AU - Shibamoto, K.

AU - Soda, Y.

AU - Kojima, K.

AU - Matsui, Y.

AU - Fujiwara, H.

AU - Hiraki, T.

AU - Gobara, H.

AU - Kanazawa, S.

PY - 2014/4

Y1 - 2014/4

N2 - Sclerotherapy is a mainstay in the treatment of venous malformations (VMs). Indications for sclerotherapy of VMs include symptoms such as pain, swelling, hemorrhage, or dysfunction of adjacent organs. Ethanol and detergent sclerosants (for example polidocanol and ethanolamine oleate) are amongst the sclerosants used to treat VMs. To increase the volume and effect of detergent sclerosants, they may be mixed with gas to form a foam. The predictors of a good response after sclerotherapy may be small size, a well-defined margin, and good stasis of sclerosant during sclerotherapy.

AB - Sclerotherapy is a mainstay in the treatment of venous malformations (VMs). Indications for sclerotherapy of VMs include symptoms such as pain, swelling, hemorrhage, or dysfunction of adjacent organs. Ethanol and detergent sclerosants (for example polidocanol and ethanolamine oleate) are amongst the sclerosants used to treat VMs. To increase the volume and effect of detergent sclerosants, they may be mixed with gas to form a foam. The predictors of a good response after sclerotherapy may be small size, a well-defined margin, and good stasis of sclerosant during sclerotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84899977746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899977746&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84899977746

VL - 59

SP - 524

EP - 532

JO - Japanese Journal of Clinical Radiology

JF - Japanese Journal of Clinical Radiology

SN - 0009-9252

IS - 4

ER -